Organizational restructuring through a merger by absorption dated 1 July 2022, with コーアバイオテックベイ株式会社 as the surviving company and コーア製薬株式会社 as the absorbed company. The event involved the dissolution of コーア製薬株式会社 through a merger between specified companies.